NYSE:CAH - Cardinal Health Stock Price, News & Analysis

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Cardinal Health announced a quarterly dividend on Thursday, May 9th. Investors of record on Monday, July 1st will be paid a dividend of $0.4811 per share on Monday, July 15th. This represents a $1.92 dividend on an annualized basis and a yield of 3.99%. The ex-dividend date of this dividend is Friday, June 28th. This is a positive change from Cardinal Health's previous quarterly dividend of $0.48. View Cardinal Health's Dividend History.

Cardinal Health announced that its Board of Directors has approved a share repurchase program on Thursday, November 8th 2018, which authorizes the company to buyback $1,000,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to repurchase up to 6.4% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's board of directors believes its stock is undervalued.

Cardinal Health Inc (NYSE:CAH) announced its earnings results on Thursday, August, 8th. The company reported $1.11 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.93 by $0.18. The firm earned $37.35 billion during the quarter, compared to analysts' expectations of $36.70 billion. Cardinal Health had a net margin of 0.94% and a return on equity of 25.96%. The business's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.01 EPS. View Cardinal Health's Earnings History.

Cardinal Health is scheduled to release their next quarterly earnings announcement on Thursday, November 14th 2019. View Earnings Estimates for Cardinal Health.

Cardinal Health issued an update on its FY20 earnings guidance on Thursday, August, 8th. The company provided earnings per share (EPS) guidance of $4.85 to $5.10 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.10.

9 equities research analysts have issued 12-month price targets for Cardinal Health's stock. Their predictions range from $41.00 to $61.00. On average, they expect Cardinal Health's share price to reach $52.8571 in the next year. This suggests a possible upside of 9.5% from the stock's current price. View Analyst Price Targets for Cardinal Health.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 2 sell ratings, 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cardinal Health.

News stories about CAH stock have trended negative recently, InfoTrie reports. The research group identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Cardinal Health earned a media sentiment score of -2.9 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for Cardinal Health.

Some companies that are related to Cardinal Health include McKesson (MCK), AmerisourceBergen (ABC), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), PetIQ (PETQ), Trxade Group (TRXD), biOasis Technologies (BIOAF) and Aceto (ACET).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AT&T (T), AbbVie (ABBV), Johnson & Johnson (JNJ), CVS Health (CVS), Exxon Mobil (XOM), Becton Dickinson and (BDX), General Electric (GE), Gilead Sciences (GILD), Verizon Communications (VZ) and Pfizer (PFE).

Cardinal Health's stock is owned by many different of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (12.01%), BlackRock Inc. (7.27%), BlackRock Inc. (7.27%), Bank of New York Mellon Corp (2.76%), Invesco Ltd. (2.73%) and American International Group Inc. (2.35%). Company insiders that own Cardinal Health stock include Jon L Giacomin, Michael C Kaufmann, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.

CAH stock was sold by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Barrow Hanley Mewhinney & Strauss LLC, Barrow Hanley Mewhinney & Strauss LLC, BlackRock Inc., BlackRock Inc., Morgan Stanley, Van ECK Associates Corp and American International Group Inc.. View Insider Buying and Selling for Cardinal Health.

CAH stock was purchased by a variety of institutional investors in the last quarter, including Swedbank, Invesco Ltd., Nuveen Asset Management LLC, Vanguard Group Inc., Pzena Investment Management LLC, Royal Bank of Canada, AXA and Canada Pension Plan Investment Board. View Insider Buying and Selling for Cardinal Health.

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CAH stock can currently be purchased for approximately $48.26.

Cardinal Health has a market capitalization of $14.39 billion and generates $145.53 billion in revenue each year. The company earns $1.36 billion in net income (profit) each year or $5.28 on an earnings per share basis. Cardinal Health employs 31,000 workers across the globe.View Additional Information About Cardinal Health.

The official website for Cardinal Health is http://www.cardinalhealth.com/.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]